Clinical recovery of Macaca fascicularis infected with Plasmodium knowlesi.

Anaemia Bone marrow Cynomolgus monkeys Fever Histopathology Infectious diseases resilience Malaria Nonhuman primate models Telemetry Thrombocytopenia

Journal

Malaria journal
ISSN: 1475-2875
Titre abrégé: Malar J
Pays: England
ID NLM: 101139802

Informations de publication

Date de publication:
30 Dec 2021
Historique:
received: 18 06 2021
accepted: 24 09 2021
entrez: 31 12 2021
pubmed: 1 1 2022
medline: 12 1 2022
Statut: epublish

Résumé

Kra monkeys (Macaca fascicularis), a natural host of Plasmodium knowlesi, control parasitaemia caused by this parasite species and escape death without treatment. Knowledge of the disease progression and resilience in kra monkeys will aid the effective use of this species to study mechanisms of resilience to malaria. This longitudinal study aimed to define clinical, physiological and pathological changes in kra monkeys infected with P. knowlesi, which could explain their resilient phenotype. Kra monkeys (n = 15, male, young adults) were infected intravenously with cryopreserved P. knowlesi sporozoites and the resulting parasitaemias were monitored daily. Complete blood counts, reticulocyte counts, blood chemistry and physiological telemetry data (n = 7) were acquired as described prior to infection to establish baseline values and then daily after inoculation for up to 50 days. Bone marrow aspirates, plasma samples, and 22 tissue samples were collected at specific time points to evaluate longitudinal clinical, physiological and pathological effects of P. knowlesi infections during acute and chronic infections. As expected, the kra monkeys controlled acute infections and remained with low-level, persistent parasitaemias without anti-malarial intervention. Unexpectedly, early in the infection, fevers developed, which ultimately returned to baseline, as well as mild to moderate thrombocytopenia, and moderate to severe anaemia. Mathematical modelling and the reticulocyte production index indicated that the anaemia was largely due to the removal of uninfected erythrocytes and not impaired production of erythrocytes. Mild tissue damage was observed, and tissue parasite load was associated with tissue damage even though parasite accumulation in the tissues was generally low. Kra monkeys experimentally infected with P. knowlesi sporozoites presented with multiple clinical signs of malaria that varied in severity among individuals. Overall, the animals shared common mechanisms of resilience characterized by controlling parasitaemia 3-5 days after patency, and controlling fever, coupled with physiological and bone marrow responses to compensate for anaemia. Together, these responses likely minimized tissue damage while supporting the establishment of chronic infections, which may be important for transmission in natural endemic settings. These results provide new foundational insights into malaria pathogenesis and resilience in kra monkeys, which may improve understanding of human infections.

Sections du résumé

BACKGROUND BACKGROUND
Kra monkeys (Macaca fascicularis), a natural host of Plasmodium knowlesi, control parasitaemia caused by this parasite species and escape death without treatment. Knowledge of the disease progression and resilience in kra monkeys will aid the effective use of this species to study mechanisms of resilience to malaria. This longitudinal study aimed to define clinical, physiological and pathological changes in kra monkeys infected with P. knowlesi, which could explain their resilient phenotype.
METHODS METHODS
Kra monkeys (n = 15, male, young adults) were infected intravenously with cryopreserved P. knowlesi sporozoites and the resulting parasitaemias were monitored daily. Complete blood counts, reticulocyte counts, blood chemistry and physiological telemetry data (n = 7) were acquired as described prior to infection to establish baseline values and then daily after inoculation for up to 50 days. Bone marrow aspirates, plasma samples, and 22 tissue samples were collected at specific time points to evaluate longitudinal clinical, physiological and pathological effects of P. knowlesi infections during acute and chronic infections.
RESULTS RESULTS
As expected, the kra monkeys controlled acute infections and remained with low-level, persistent parasitaemias without anti-malarial intervention. Unexpectedly, early in the infection, fevers developed, which ultimately returned to baseline, as well as mild to moderate thrombocytopenia, and moderate to severe anaemia. Mathematical modelling and the reticulocyte production index indicated that the anaemia was largely due to the removal of uninfected erythrocytes and not impaired production of erythrocytes. Mild tissue damage was observed, and tissue parasite load was associated with tissue damage even though parasite accumulation in the tissues was generally low.
CONCLUSIONS CONCLUSIONS
Kra monkeys experimentally infected with P. knowlesi sporozoites presented with multiple clinical signs of malaria that varied in severity among individuals. Overall, the animals shared common mechanisms of resilience characterized by controlling parasitaemia 3-5 days after patency, and controlling fever, coupled with physiological and bone marrow responses to compensate for anaemia. Together, these responses likely minimized tissue damage while supporting the establishment of chronic infections, which may be important for transmission in natural endemic settings. These results provide new foundational insights into malaria pathogenesis and resilience in kra monkeys, which may improve understanding of human infections.

Identifiants

pubmed: 34969401
doi: 10.1186/s12936-021-03925-6
pii: 10.1186/s12936-021-03925-6
pmc: PMC8719393
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

486

Subventions

Organisme : NIGMS NIH HHS
ID : T32 GM008169
Pays : United States
Organisme : NIH HHS
ID : P51 OD011132
Pays : United States
Organisme : NIAID NIH HHS
ID : HHSN272201200031C
Pays : United States
Organisme : CLC NIH HHS
ID : C0000008
Pays : United States
Organisme : defense advanced research projects agency
ID : W911NF16C0008
Organisme : nih office of research infrastructure programs
ID : P51OD011132

Investigateurs

Dave C Anderson (DC)
Ferhat Ay (F)
Cristiana F A Brito (CFA)
John W Barnwell (JW)
Megan DeBarry (M)
Steven E Bosinger (SE)
Jung-Ting Chien (JT)
Jinho Choi (J)
Anuj Gupta (A)
Chris Ibegbu (C)
Xuntian Jiang (X)
Dean P Jones (DP)
Nicolas Lackman (N)
Tracey J Lamb (TJ)
Frances E-H Lee (FE)
Karine Gaelle Le Roche (KG)
Shuzhao Li (S)
Esmeralda V S Meyer (EVS)
Diego M Moncada-Giraldo (DM)
Dan Ory (D)
Jan Pohl (J)
Saeid Safaei (S)
Igñacio Sanz (I)
Maren Smith (M)
Gregory Tharp (G)
ViLinh Tran (V)
Elizabeth D Trippe (ED)
Karan Uppal (K)
Susanne Warrenfeltz (S)
Tyrone Williams (T)
Zerotti L Woods (ZL)

Informations de copyright

© 2021. The Author(s).

Références

Am J Trop Med Hyg. 2020 Sep;103(3):1107-1110
pubmed: 32618263
Lancet. 2004 Mar 27;363(9414):1017-24
pubmed: 15051281
Parasitology. 2018 Jan;145(1):85-100
pubmed: 28712361
Malar J. 2012 Dec 05;11:401
pubmed: 23216947
Immunology. 1972 Oct;23(4):503-21
pubmed: 4628462
Int J Biol Sci. 2011;7(9):1427-42
pubmed: 22110393
Am J Trop Med Hyg. 2007 Apr;76(4):648-54
pubmed: 17426164
J Infect Dis. 2016 Mar 1;213(5):784-7
pubmed: 26433222
Br J Haematol. 1987 Dec;67(4):473-8
pubmed: 3322362
Ind Med Gaz. 1932 Jun;67(6):301-320
pubmed: 29010910
Malar J. 2018 Oct 19;17(1):371
pubmed: 30340592
Clin Infect Dis. 2020 Jan 16;70(3):361-367
pubmed: 30889244
Parasitol Today. 1996 Oct;12(10):378-82
pubmed: 15275287
Science. 1965 Aug 20;149(3686):865
pubmed: 14332847
Trends Parasitol. 2008 Sep;24(9):406-10
pubmed: 18678527
Malar J. 2016 Aug 12;15(1):410
pubmed: 27520455
Malar J. 2018 Nov 6;17(1):410
pubmed: 30400896
Nat Commun. 2016 Apr 04;7:11187
pubmed: 27041489
Infect Immun. 1983 Jun;40(3):985-94
pubmed: 6189787
Am J Trop Med Hyg. 1971 Nov;20(6):816-24
pubmed: 5002246
Clin Microbiol Rev. 2013 Apr;26(2):165-84
pubmed: 23554413
PLoS Pathog. 2011 Apr;7(4):e1002015
pubmed: 21490952
J Infect Dis. 2014 Jan 1;209(1):140-9
pubmed: 23922378
Emerg Infect Dis. 2020 Aug;26(8):1801-1809
pubmed: 32687020
Blood Adv. 2018 Feb 27;2(4):433-443
pubmed: 29487058
Malar J. 2019 Mar 8;18(1):66
pubmed: 30849978
Clin Infect Dis. 2013 Feb;56(3):383-97
pubmed: 23087389
Malar J. 2017 Mar 31;16(1):135
pubmed: 28359340
J Clin Invest. 1971 Jul;50(7):1451-5
pubmed: 4996884
Malar J. 2017 Sep 22;16(1):384
pubmed: 28938907
J Infect Dis. 2017 Apr 1;215(7):1148-1155
pubmed: 28201638
Parasitology. 2018 Jan;145(1):71-84
pubmed: 28720171
Trans R Soc Trop Med Hyg. 2010 Jan;104(1):75-7
pubmed: 19699500
Open Forum Infect Dis. 2019 Jan 19;6(3):ofz021
pubmed: 30937329
Int J Parasitol. 1973 May;3(3):443-5
pubmed: 4200011
J Physiol Anthropol. 2020 Nov 23;39(1):36
pubmed: 33228775
Nucleic Acids Res. 2009 Jan;37(Database issue):D539-43
pubmed: 18957442
Emerg Infect Dis. 2011 May;17(5):814-20
pubmed: 21529389
Sci Rep. 2021 Sep 30;11(1):19519
pubmed: 34593836
Blood. 2004 May 15;103(10):3727-35
pubmed: 14739226
Vet Pathol. 1978 Jan;15(1):83-91
pubmed: 415405
Malar J. 2017 Sep 18;16(1):375
pubmed: 28923058
Parasit Vectors. 2008 Aug 19;1(1):26
pubmed: 18710577
Emerg Infect Dis. 2016 Jan;22(1):41-8
pubmed: 26690736
J Infect Dis. 2019 Feb 15;219(5):695-702
pubmed: 30295822
Clin Infect Dis. 2009 Sep 15;49(6):852-60
pubmed: 19635025
Exp Parasitol. 2010 Feb;124(2):181-9
pubmed: 19765587
Trends Parasitol. 2017 Mar;33(3):242-253
pubmed: 27707609
Malar J. 2010 Jan 11;9:10
pubmed: 20064229
Trop Med Int Health. 2014 Sep;19 Suppl 1:7-131
pubmed: 25214480
Malar J. 2014 Feb 24;13:68
pubmed: 24564912
Emerg Infect Dis. 2020 Jul;26(7):1392-1398
pubmed: 32568035
Vet Pathol. 2015 Nov;52(6):998-1011
pubmed: 26077782
Malar J. 2020 Oct 1;19(1):350
pubmed: 33004070
PLoS Negl Trop Dis. 2016 Oct 14;10(10):e0005064
pubmed: 27741235
Malar J. 2016 Sep 02;15(1):451
pubmed: 27590312
Clin Infect Dis. 2018 Jul 18;67(3):350-359
pubmed: 29873683
Infect Immun. 2013 Jun;81(6):1889-904
pubmed: 23509137
Clin Infect Dis. 2008 Jan 15;46(2):165-71
pubmed: 18171245
Nature. 1965 Dec 25;208(5017):1286-8
pubmed: 4958335
Malar J. 2019 May 2;18(1):156
pubmed: 31046769
Sci Rep. 2019 Dec 12;9(1):18965
pubmed: 31831787
Parasitology. 2018 Jan;145(1):18-31
pubmed: 28122651
Parasitology. 1999 Aug;119 ( Pt 2):127-33
pubmed: 10466119
Mem Inst Oswaldo Cruz. 2011 Aug;106 Suppl 1:52-63
pubmed: 21881757
Am J Trop Med Hyg. 1977 Jul;26(4):612-22
pubmed: 407808
PLoS Pathog. 2015 May 28;11(5):e1004888
pubmed: 26020959
JCI Insight. 2019 May 2;4(9):
pubmed: 31045574
Parasitology. 2018 Jan;145(1):56-70
pubmed: 27938428
Am J Trop Med Hyg. 2017 Aug;97(2):548-555
pubmed: 28829738
Math Biosci. 2015 Dec;270(Pt B):224-36
pubmed: 26362230
Emerg Infect Dis. 2011 Jul;17(7):1248-55
pubmed: 21762579
J Parasitol. 1992 Jun;78(3):505-11
pubmed: 1597796
Emerg Infect Dis. 2016 Feb;22(2):201-8
pubmed: 26812373
PLoS Biol. 2020 Jul 14;18(7):e3000410
pubmed: 32663219
Blood. 2018 Sep 20;132(12):1332-1344
pubmed: 30026183
Blood. 2007 Jul 1;110(1):18-28
pubmed: 17341664
Ind Med Gaz. 1932 May;67(5):246-249
pubmed: 29011028
Clin Infect Dis. 2019 Oct 30;69(10):1703-1711
pubmed: 30624597
J Natl Malar Soc. 1945 Dec;4:285-300
pubmed: 21016051
Annu Rev Entomol. 2012;57:107-21
pubmed: 22149265
Am J Trop Med Hyg. 2003 Apr;68(4):410-2
pubmed: 12875288

Auteurs

Mariko S Peterson (MS)

Yerkes National Primate Research Center, Emory University, Atlanta, GA, USA.
Emory Vaccine Center, Emory University, Atlanta, GA, USA.
Emory University School of Medicine, Atlanta, GA, USA.

Chester J Joyner (CJ)

Yerkes National Primate Research Center, Emory University, Atlanta, GA, USA.
Emory Vaccine Center, Emory University, Atlanta, GA, USA.
Center for Vaccines and Immunology, Department of Infectious Diseases, University of Georgia, Athens, GA, USA.
Center for Vaccines and Immunology, Department of Infectious Diseases, College of Veterinary Medicine, University of Georgia, Athens, GA, USA.

Jessica A Brady (JA)

School of Chemical, Materials and Biomedical Engineering, University of Georgia, Athens, GA, USA.
Eli Lilly and Company, Indianapolis, IN, USA.

Jennifer S Wood (JS)

Division of Animal Resources, Yerkes National Primate Research Center, Emory University, Atlanta, GA, USA.

Monica Cabrera-Mora (M)

Yerkes National Primate Research Center, Emory University, Atlanta, GA, USA.
Emory Vaccine Center, Emory University, Atlanta, GA, USA.
College of Veterinary Medicine, University of Georgia, Athens, GA, USA.

Celia L Saney (CL)

Yerkes National Primate Research Center, Emory University, Atlanta, GA, USA.
Emory Vaccine Center, Emory University, Atlanta, GA, USA.

Luis L Fonseca (LL)

The Wallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology and Emory University, Atlanta, GA, USA.
Division of Pulmonary, Critical Care, and Sleep Medicine, Department of Medicine, College of Medicine, University of Florida, Gainesville, FL, USA.

Wayne T Cheng (WT)

Center for Vaccines and Immunology, Department of Infectious Diseases, University of Georgia, Athens, GA, USA.

Jianlin Jiang (J)

Yerkes National Primate Research Center, Emory University, Atlanta, GA, USA.
Emory Vaccine Center, Emory University, Atlanta, GA, USA.

Stacey A Lapp (SA)

Yerkes National Primate Research Center, Emory University, Atlanta, GA, USA.
Emory Vaccine Center, Emory University, Atlanta, GA, USA.

Stephanie R Soderberg (SR)

Yerkes National Primate Research Center, Emory University, Atlanta, GA, USA.
Emory Vaccine Center, Emory University, Atlanta, GA, USA.
Thermo Fisher Scientific, South San Francisco, CA, USA.

Mustafa V Nural (MV)

Institute of Bioinformatics, University of Georgia, Athens, GA, USA.

Jay C Humphrey (JC)

Institute of Bioinformatics, University of Georgia, Athens, GA, USA.
Center for Tropical & Emerging Global Diseases, University of Georgia, Athens, GA, USA.

Allison Hankus (A)

Yerkes National Primate Research Center, Emory University, Atlanta, GA, USA.
Emory Vaccine Center, Emory University, Atlanta, GA, USA.
The MITRE Corporation, Atlanta, GA, USA.

Deepa Machiah (D)

Division of Pathology, Yerkes National Primate Research Center, Atlanta, GA, USA.

Ebru Karpuzoglu (E)

Yerkes National Primate Research Center, Emory University, Atlanta, GA, USA.
Emory Vaccine Center, Emory University, Atlanta, GA, USA.
Department of Biosciences and Diagnostic Imaging, College of Veterinary Medicine, University of Georgia, Athens, GA, USA.

Jeremy D DeBarry (JD)

Institute of Bioinformatics, University of Georgia, Athens, GA, USA.
Center for Topical and Emerging Global Diseases, University of Georgia, Athens, GA, USA.

Rabindra Tirouvanziam (R)

Department of Pediatrics, Emory University School of Medicine, Atlanta, GA, USA.

Jessica C Kissinger (JC)

Institute of Bioinformatics, University of Georgia, Athens, GA, USA.
Department of Genetics, University of Georgia, Athens, GA, USA.
Center for Tropical and Emerging Global Diseases, University of Georgia, Athens, GA, USA.

Alberto Moreno (A)

Yerkes National Primate Research Center, Emory University, Atlanta, GA, USA.
Emory Vaccine Center, Emory University, Atlanta, GA, USA.
Division of Infectious Diseases, Department of Medicine, Emory University School of Medicine, Atlanta, GA, USA.

Sanjeev Gumber (S)

Division of Pathology, Yerkes National Primate Research Center, Atlanta, GA, USA.
Department of Pathology and Laboratory Medicine, Emory School of Medicine, Atlanta, GA, USA.
Pathology, Drug Safety, and DMPK, Boehringer Ingelheim Animal Health USA, Inc., Athens, GA, USA.

Eberhard O Voit (EO)

The Wallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology and Emory University, Atlanta, GA, USA.

Juan B Gutiérrez (JB)

Department of Mathematics, University of Georgia, Athens, GA, USA.
Department of Mathematics, University of Texas at San Antonio, San Antonio, TX, USA.

Regina Joice Cordy (RJ)

Yerkes National Primate Research Center, Emory University, Atlanta, GA, USA.
Emory Vaccine Center, Emory University, Atlanta, GA, USA.
Department of Biology, Wake Forest University, Winston-Salem, NC, USA.

Mary R Galinski (MR)

Yerkes National Primate Research Center, Emory University, Atlanta, GA, USA. Mary.Galinski@emory.edu.
Emory Vaccine Center, Emory University, Atlanta, GA, USA. Mary.Galinski@emory.edu.
Division of Infectious Diseases, Department of Medicine, Emory University School of Medicine, Atlanta, GA, USA. Mary.Galinski@emory.edu.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH